Publication | Closed Access
Suppression of Testosterone and Androstenedione Production Rates with Dexamethasone in Women with Idiopathic Hirsutism and Polycystic Ovaries
78
Citations
1
References
1968
Year
FertilityDexamethasone AdministrationReproductive HealthNeuroendocrinologyGynecologyPolycystic OvariesPolycystic Ovary SyndromeFemale Reproductive SystemFemale Reproductive FunctionOvarian AgingReproductive EndocrinologyFemale InfertilityReproductive MedicineWomen's PhysiologyPublic HealthSteroid MetabolismReproductive HormoneNormal WomenIdiopathic HirsutismInfertilityAndrologyAndrostenedione ProductionEndocrine MechanismEndocrinologyOvarian HormoneUrologyPhysiologyMenopauseMedicineEndocrine ResearchWomen's Health
Testosterone and androstenedione plasma levels were measured in 7 normal women and 22 hirsute women with either idiopathic hirsutism (IH) or polycystic ovaries (PCO). During dexamethasone administration, plasma testosterone decreased 25% in normal subjects and 40–50% in the patients with IH and PCO. Plasma androstenedione levels were suppressed 40–55% in the normal and hirsute women. The mean testosterone metabolic clearance rate for 8 hirsute women increased 10 % during dexamethasone administration but there was no significant change in the androstpnedione metabolic clearance. Thus, the decrease in blood androgen levels produced by glucocorticoid was a consequence of decreased androgen production. These studies indicate further that a gland which is suppressed by dexamethasone is responsible for a significant fraction of the excess androgen production in women with either IH or PCO.
| Year | Citations | |
|---|---|---|
Page 1
Page 1